The potent small molecule integrin antagonist THR-687 is a promising next-generation therapy for retinal vascular disorders
Autor: | Hu, Tjing-Tjing, Vanhove, Marc, Porcu, Michaël, Van Hove, Inge, Van Bergen, Tine, Jonckx, Bart, Barbeaux, Philippe, Vermassen, Elke, Feyen, Jean H.M. |
---|---|
Zdroj: | In Experimental Eye Research March 2019 180:43-52 |
Databáze: | ScienceDirect |
Externí odkaz: |